These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 18403221

  • 1. The type II collagen fragments Helix-II and CTX-II reveal different enzymatic pathways of human cartilage collagen degradation.
    Charni-Ben Tabassi N, Desmarais S, Bay-Jensen AC, Delaissé JM, Percival MD, Garnero P.
    Osteoarthritis Cartilage; 2008 Oct; 16(10):1183-91. PubMed ID: 18403221
    [Abstract] [Full Text] [Related]

  • 2. Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation.
    Sondergaard BC, Henriksen K, Wulf H, Oestergaard S, Schurigt U, Bräuer R, Danielsen I, Christiansen C, Qvist P, Karsdal MA.
    Osteoarthritis Cartilage; 2006 Aug; 14(8):738-48. PubMed ID: 16563811
    [Abstract] [Full Text] [Related]

  • 3. Biochemical markers of type II collagen breakdown and synthesis are positioned at specific sites in human osteoarthritic knee cartilage.
    Bay-Jensen AC, Andersen TL, Charni-Ben Tabassi N, Kristensen PW, Kjaersgaard-Andersen P, Sandell L, Garnero P, Delaissé JM.
    Osteoarthritis Cartilage; 2008 May; 16(5):615-23. PubMed ID: 17950629
    [Abstract] [Full Text] [Related]

  • 4. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.
    Garnero P, Ayral X, Rousseau JC, Christgau S, Sandell LJ, Dougados M, Delmas PD.
    Arthritis Rheum; 2002 Oct; 46(10):2613-24. PubMed ID: 12384919
    [Abstract] [Full Text] [Related]

  • 5. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N, Juillet F, Garnero P.
    Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
    [Abstract] [Full Text] [Related]

  • 6. GPDPLQ1237-A Type II Collagen Neo-Epitope Biomarker of Osteoclast- and Inflammation-Derived Cartilage Degradation in vitro.
    Löfvall H, Katri A, Dąbrowska A, Karsdal MA, Luo Y, He Y, Manon-Jensen T, Dziegiel MH, Bay-Jensen AC, Thudium CS, Henriksen K.
    Sci Rep; 2019 Feb 28; 9(1):3050. PubMed ID: 30816326
    [Abstract] [Full Text] [Related]

  • 7. The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation.
    Garnero P, Ferreras M, Karsdal MA, Nicamhlaoibh R, Risteli J, Borel O, Qvist P, Delmas PD, Foged NT, Delaissé JM.
    J Bone Miner Res; 2003 May 28; 18(5):859-67. PubMed ID: 12733725
    [Abstract] [Full Text] [Related]

  • 8. Increased cartilage type II collagen degradation in patients with osteogenesis imperfecta used as a human model of bone type I collagen alterations.
    Rousseau JC, Chevrel G, Schott AM, Garnero P.
    Bone; 2010 Apr 28; 46(4):897-900. PubMed ID: 20005316
    [Abstract] [Full Text] [Related]

  • 9. Cartilage destruction in collagen induced arthritis assessed with a new biochemical marker for collagen type II C-telopeptide fragments.
    Ishikawa T, Nishigaki F, Christgau S, Noto T, Mo J, From N, Minoura K, Hirayama Y, Ohkubo Y, Mutoh S.
    J Rheumatol; 2004 Jun 28; 31(6):1174-9. PubMed ID: 15170932
    [Abstract] [Full Text] [Related]

  • 10. Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI.
    Dam EB, Byrjalsen I, Karsdal MA, Qvist P, Christiansen C.
    Osteoarthritis Cartilage; 2009 Mar 28; 17(3):384-9. PubMed ID: 18768336
    [Abstract] [Full Text] [Related]

  • 11. The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis.
    Lohmander LS, Atley LM, Pietka TA, Eyre DR.
    Arthritis Rheum; 2003 Nov 28; 48(11):3130-9. PubMed ID: 14613275
    [Abstract] [Full Text] [Related]

  • 12. Anabolic and catabolic function of chondrocyte ex vivo is reflected by the metabolic processing of type II collagen.
    Olsen AK, Sondergaard BC, Byrjalsen I, Tanko LB, Christiansen C, Müller A, Hein GE, Karsdal MA, Qvist P.
    Osteoarthritis Cartilage; 2007 Mar 28; 15(3):335-42. PubMed ID: 17045814
    [Abstract] [Full Text] [Related]

  • 13. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis.
    Squires GR, Okouneff S, Ionescu M, Poole AR.
    Arthritis Rheum; 2003 May 28; 48(5):1261-70. PubMed ID: 12746899
    [Abstract] [Full Text] [Related]

  • 14. Evidence to suggest that cathepsin K degrades articular cartilage in naturally occurring equine osteoarthritis.
    Vinardell T, Dejica V, Poole AR, Mort JS, Richard H, Laverty S.
    Osteoarthritis Cartilage; 2009 Mar 28; 17(3):375-83. PubMed ID: 18809344
    [Abstract] [Full Text] [Related]

  • 15. Knee cartilage defects: association with early radiographic osteoarthritis, decreased cartilage volume, increased joint surface area and type II collagen breakdown.
    Ding C, Garnero P, Cicuttini F, Scott F, Cooley H, Jones G.
    Osteoarthritis Cartilage; 2005 Mar 28; 13(3):198-205. PubMed ID: 15727885
    [Abstract] [Full Text] [Related]

  • 16. Increased urinary concentration of collagen type II C-telopeptide fragments in patients with osteoarthritis.
    Jung M, Christgau S, Lukoschek M, Henriksen D, Richter W.
    Pathobiology; 2004 Mar 28; 71(2):70-6. PubMed ID: 14707441
    [Abstract] [Full Text] [Related]

  • 17. Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate.
    Christgau S, Henrotin Y, Tankó LB, Rovati LC, Collette J, Bruyere O, Deroisy R, Reginster JY.
    Clin Exp Rheumatol; 2004 Mar 28; 22(1):36-42. PubMed ID: 15005002
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of cartilage damage by measuring collagen degradation products in joint extracts in a traumatic model of osteoarthritis.
    Nielsen RH, Stoop R, Leeming DJ, Stolina M, Qvist P, Christiansen C, Karsdal MA.
    Biomarkers; 2008 Feb 28; 13(1):79-87. PubMed ID: 17852072
    [Abstract] [Full Text] [Related]

  • 19. Effects of ovariectomy and estrogen therapy on type II collagen degradation and structural integrity of articular cartilage in rats: implications of the time of initiation.
    Oestergaard S, Sondergaard BC, Hoegh-Andersen P, Henriksen K, Qvist P, Christiansen C, Tankó LB, Karsdal MA.
    Arthritis Rheum; 2006 Aug 28; 54(8):2441-51. PubMed ID: 16871544
    [Abstract] [Full Text] [Related]

  • 20. A critical role for collagen II in cartilage matrix degradation: collagen II induces pro-inflammatory cytokines and MMPs in primary human chondrocytes.
    Klatt AR, Paul-Klausch B, Klinger G, Kühn G, Renno JH, Banerjee M, Malchau G, Wielckens K.
    J Orthop Res; 2009 Jan 28; 27(1):65-70. PubMed ID: 18655132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.